Taurin, Sebastien <br/><br/>
A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines.  [electronic resource] 

 -  International journal of oncology  Jan 2016 
 - 385-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2423 
<br/><br/><label>Standard No.: </label>10.3892/ijo.2015.3252  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Breast Neoplasms--drug therapy<br/>Caspase 3--metabolism<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Curcumin--administration & dosage<br/>Drug Synergism<br/>Female<br/>Human Umbilical Vein Endothelial Cells<br/>Humans<br/>Neoplasm Invasiveness--genetics<br/>Raloxifene Hydrochloride--administration & dosage<br/>Receptors, Estrogen--genetics<br/>Signal Transduction--drug effects